Non-cytotoxic nanoparticles re-educating macrophages achieving both innate and adaptive immune responses for tumor therapy
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science,Pharmacology
Reference58 articles.
1. Engineering prodrug nanomedicine for cancer immunotherapy;Yang;Adv Sci,2020
2. De-novo and acquired resistance to immune checkpoint targeting;Syn;Lancet Oncol,2017
3. Improving cancer immunotherapy through nanotechnology;Goldberg;Nat Rev Cancer,2019
4. Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics;Buss;Proc Natl Acad Sci U S A,2020
5. Synergetic functional nanocomposites enhance immunotherapy in solid tumors by remodeling the immunoenvironment;Yang;Adv Sci,2019
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature;Cancer Immunology, Immunotherapy;2024-08-06
2. Application of nanoscale metal–organic frameworks in tumor immunotherapy;Rare Metals;2024-06-18
3. Targeting PI3K-gamma in myeloid driven tumour immune suppression: A Systematic Review and Meta-Analysis of the Preclinical Literature;2024-05-14
4. Supramolecular self‐assembled nanoparticles for targeted therapy of myocardial infarction by enhancing cardiomyocyte mitophagy;Aggregate;2024-04-22
5. An Epic Advancement in Targeting Macrophages for Cancer Therapy Approach;Current Drug Delivery;2024-04-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3